Skip to main content
Clinical Trials/NCT04305730
NCT04305730UnknownNot Applicable

Does the Use of a Post-Operative Pedometer Affect Rate of Return of Bowel Function and Narcotic Use Following Radical Cystectomy

Benaroya Research Institute1 site in 1 country35 target enrollmentStarted: March 1, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
35
Locations
1
Primary Endpoint
Rate of return of bowel function

Study Overview

Brief Summary

This is a study to evaluate whether use of a pedometer following radical cystectomy decreases post-operative narcotic use and time to return of bowel function.

Detailed Description

This is a randomized controlled prospective study looking at the effect of using a pedometer with graduated step-count goals following radical cystectomy on rate of ileus, return of bowel function and post-operative narcotic use. Subjects will be randomized into a control group or study group. The control group will receive standard of care, with information provided regarding the importance of ambulation following surgery. The study group will receive a pedometer with graduated step-count goals from post-operative day 0 to post-operative day 21. Both groups will be given a standardized post-operative narcotic regimen, and will be asked to record initial passage of flatus and first bowel movement. Subjects will remain on the study until post-operative day 21.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •This study will include men and women age18-75 undergoing radical cystectomy for bladder cancer at Virginia Mason Medical Center. This includes both open and robot-assisted radical cystectomy, and all types of urinary diversion will be included in the trial. Subjects both with and without neo-adjuvant chemotherapy will be included in the study.

Exclusion Criteria

  • •Long-term opioid use, defined by CDC as use of opioids on most days for >3 months
  • •History of inflammatory bowel disease
  • •Prior abdominopelvic radiation
  • •Travel to Europe during study period
  • •Concurrent surgery during radical cystectomy
  • •Inability to ambulate
  • •Gastroparesis or other baseline bowel dysmotility issues
  • •Inability or unwillingness of subject or legal guardian/representative to give written informed consent.

Arms & Interventions

Pedometer Group

Experimental

This group will be given a pedometer following radical cystectomy. Subjects in the experimental group will have a graduated step-count goal as follows: POD 0-2: 1,000/day. POD 3-6: 2,000/day. POD 7-9: 3,000/day. POD 10-14: 4,000/day. POD 14-21: 5,000

Intervention: Use of a pedometer following surgery (Behavioral)

Control group

Active Comparator

This is the control group. Following radical cystectomy subjects in the control group will receive standard of care, which includes counseling regarding the importance of ambulation following surgery.

Intervention: Standard of care (Behavioral)

Outcomes

Primary Outcomes

Rate of return of bowel function

Time Frame: 5-15 days

First passage of flatus/stool

Rate of post-operative ileus

Time Frame: 7-21 days

Standard definition

Secondary Outcomes

  • Post-operative narcotic use(7-21 days)
  • Post-operative pain scores(1-21 days)
  • Hospital length of stay(3-14 days)
  • Length of time under general anesthesia(180-420 minutes)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials